Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-20-003929
Filing Date
2020-01-17
Accepted
2020-01-17 16:05:08
Documents
2
Period of Report
2020-01-15

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1581
2 POA DOCUMENT poa.txt EX-24.3_889278 3038
  Complete submission text file 0001209191-20-003929.txt   6083
Mailing Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080 650-871-0761
CATALYST BIOSCIENCES, INC. (Issuer) CIK: 0001124105 (see all company filings)

EIN.: 562020050 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CATALYST BIOSCIENCES, INC. 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080
Business Address
TETLOW SHARON (Reporting) CIK: 0001328565 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-51173 | Film No.: 20533595